Literature DB >> 18612601

T cell - primary culture from peripheral blood.

Monika Raulf-Heimsoth1.   

Abstract

Peripheral blood mononuclear cells (PBMC) can be used to assess cell-mediated immunity in general or, via antigen-specific stimulation, to detect previous exposure to a variety of antigens/allergens and to monitor the response to immunotherapies. Peripheral blood is the most common source of mononuclear cells for in vitro cultures, although mononuclear cells can be obtained from other sources involved in the allergic reaction. PBMC from individuals previously exposed to an antigen proliferate in vitro when stimulated with the specific antigen. Proliferation is measured by the incorporation of ((3)H)-thymidine into newly synthesized DNA. This parameter is often used as an end point of lymphocyte stimulation induced by antigen or antigen fragments (e.g., synthetic peptides), mitogens, or anti-CD3/anti-CD28 combinations. The aim of this chapter is to describe the culture of T cells obtained from peripheral blood and the collection of cell supernatants for cytokine measurement.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18612601     DOI: 10.1007/978-1-59745-366-0_2

Source DB:  PubMed          Journal:  Methods Mol Med        ISSN: 1543-1894


  2 in total

1.  Design and Synthesis of Non-Peptide Mimetics Mapping the Immunodominant Myelin Basic Protein (MBP83-96) Epitope to Function as T-Cell Receptor Antagonists.

Authors:  Mary-Patricia Yannakakis; Carmen Simal; Haralambos Tzoupis; Maria Rodi; Narges Dargahi; Monica Prakash; Athanasia Mouzaki; James A Platts; Vasso Apostolopoulos; Theodore V Tselios
Journal:  Int J Mol Sci       Date:  2017-06-08       Impact factor: 5.923

2.  In vitro assessment of the feline cell-mediated immune response against feline panleukopeniavirus, calicivirus and felid herpesvirus 1 using 5-bromo-2'-deoxyuridine labeling.

Authors:  Ben L Vermeulen; Sabine E Gleich; Annelike Dedeurwaerder; Dominique A Olyslaegers; Lowiese M Desmarets; Hannah L Dewerchin; Hans J Nauwynck
Journal:  Vet Immunol Immunopathol       Date:  2012-03-10       Impact factor: 2.046

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.